Michael Mithoefer, MD, Clinical Assistant Professor of Psychiatry at the Medical University of South Carolina. In 2009, he has completed the first FDA approved clinical trial of MDMA-assisted psychotherapy in military veterans, firefighters and police officers with PTSD.
Financial: Dr. Michael Mithoefer has employment relationships with Bassett Healthcare Network, Medical University of South Carolina, and MAPS Public Benefit Corporation. He has an ownership interest in Awakn Life Sciences and serves on the scientific advisory board. Dr. Mithoefer receives a speaking honorarium and recording royalties from PESI, Inc.
Non-financial: Dr. Michael Mithoefer is a fellow of the American Psychiatric Association.